Efficacy and Feasibility of Camrelizumab Combined with Conventional Dual Chemotherapy Regimen in Advanced Non-squamous Non-small Cell Lung Cancer

YAO Fenglong; WANG Weidong; GUO Jiayou

doi:10.14033/j.cnki.cfmr.2022.22.005

Home>Articles>Efficacy and Feasibility of Camrelizumab Combined with Conventional Dual Chemotherapy Regimen in Advanced Non-squamous Non-small Cell Lung Cancer

DOI: 10.14033/j.cnki.cfmr.2022.22.005

Efficacy and Feasibility of Camrelizumab Combined with Conventional Dual Chemotherapy Regimen in Advanced Non-squamous Non-small Cell Lung Cancer

YAO Fenglong

WANG Weidong

GUO Jiayou

Machine-generated Keywords：

Publication Date：2022-08-05

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 18-21 )

Chinese and Foreign Medical Research

ISSN：1674-6805

Year, Vol.(Issue)：2022,20(22)